The first randomized trial to test whether adding a small, temporary pump to allow the heart to rest and intentionally ...
Ace Therapeutics, a global leader in ophthalmic disease model development and preclinical research services, today announced its customized NHP GA model development platform focused on blue ...
The results run counter to ABYSS but align with other data showing beta-blockers shouldn’t continue indefinitely after MI.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results